Login

Financial Snapshot

Revenue
TTM
$4.893B
Gross Margin
TTM
54.9%
Net Income
TTM
-$242.0M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
215.64%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$6.500B
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$315.0M

Stock Price

Loading...
Market Cap: $11.802 Billion

About Elanco Animal Health Inc

Elanco Animal Health Inc (NYSE: ELAN) is an animal health company that develops and sells products for companion animals and farm animals. The filing excerpts provided do not contain sufficient detail to describe revenue streams, segment breakdown, product portfolio, geographic mix, or competitive position with the specificity required for a source-grounded description. All material claims would require inference beyond what the supplied excerpts support, so those details are omitted per source-grounding rules.

Source: SEC 10-K, filed 2026-02-24

Industry: Pharmaceutical Preparations Peers: Catalent, Inc. CORCEPT THERAPEUTICS INC Harmony Biosciences Holdings Inc Intra-Cellular Therapies, Inc. Johnson & Johnson Organon & Co Royalty Pharma PLC Viatris Inc Zoetis Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support